Advertisement
Screener

Elanco Animal Health Incorporated (ELAN) Auditor

Elanco Animal Health Incorporated Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-02-24: Fiscal year end 2025-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Indianapolis, Indiana.
  • 2025-02-25: Fiscal year end 2024-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Indianapolis, Indiana.
  • 2024-02-26: Fiscal year end 2023-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Indianapolis, Indiana.
  • 2023-03-01: Fiscal year end 2022-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Indianapolis, Indiana.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-02-242025-12-31Ernst & Young LLP42Indianapolis, IndianaYes
2025-02-252024-12-31Ernst & Young LLP42Indianapolis, IndianaYes
2024-02-262023-12-31Ernst & Young LLP42Indianapolis, IndianaYes
2023-03-012022-12-31Ernst & Young LLP42Indianapolis, IndianaYes
2022-02-282021-12-31Ernst & Young LLP42Indianapolis, IndianaYes
2021-03-012020-12-31Ernst & Young LLPIndianapolis, IndianaYes
2020-02-282019-12-31Ernst & Young LLPIndianapolis, Indiana
2019-02-202018-12-31Ernst & Young LLPIndianapolis, Indiana

Similar stocks

Stock NameCountryMarket CapPE Ratio
MADRIGAL PHARMACEUTICALS, INC. (MDGL)United States$11.859B-38.17
BIOMARIN PHARMACEUTICAL INC (BMRN)United States$11.879B151.80
Axsome Therapeutics, Inc. (AXSM)United States$10.274B-66.82
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)United States$9.331B-42.28
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
CYTOKINETICS INC (CYTK)United States$9.130B-11.86
Protagonist Therapeutics, Inc (PTGX)United States$8.883B95.52
TG THERAPEUTICS, INC. (TGTX)United States$8.805B19.05